Risks of Taking Entresto, Spironolactone, and Lasix Together

Major Risks

The combination of Entresto, spironolactone, and Lasix significantly increases the risk of hyperkalemia, which can lead to cardiac arrest, particularly in patients with chronic kidney disease, diabetes, and those taking high doses of spironolactone 1, 2
The European Heart Journal recommends careful monitoring of patients on this combination due to the increased risk of hyperkalemia and hypotension 1, 2
Risk factors for hyperkalemia include chronic kidney disease, spironolactone doses >25 mg daily, and concomitant use of ACE inhibitors/ARBs, with the European Heart Journal citing a significant increase in risk 2

The European Journal of Heart Failure recommends monitoring serum potassium levels at regular intervals, with dose reduction or cessation of spironolactone if potassium levels exceed 5.5 mmol/L or 6.0 mmol/L, respectively 4, 5
Regular monitoring of serum creatinine is essential, with dose adjustment or cessation of spironolactone if creatinine levels exceed 221 μmol/L or eGFR <30 mL/min/1.73 m² 4
The European Heart Journal emphasizes the importance of regular blood pressure monitoring to detect hypotension, particularly in elderly patients 2

The European Journal of Heart Failure recommends using the minimum effective dose of each medication, with consideration of lower doses in high-risk patients, such as the elderly or those with renal impairment 4, 7
Patient education is crucial, with instruction on symptoms of hyperkalemia and hypotension, and advice to avoid NSAIDs, potassium supplements, and salt substitutes high in potassium 4
The European Heart Journal suggests that patients with severe heart failure or renal dysfunction require extra caution and closer monitoring 2